Suicidal ideation and attempts following nonmedical use of prescription opioids and related disorder.
Attempted suicide
dependence
opioid abuse
opioid-related disorder
suicidal ideation
Journal
Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
pubmed:
9
7
2020
medline:
23
3
2022
entrez:
9
7
2020
Statut:
ppublish
Résumé
Since 1999, the rate of fatal prescription opioid overdoses and of suicides has dramatically increased in the USA. These increases, which have occurred among similar demographic groups, have led to the hypothesis that the opioid epidemic contributed to increases in suicidal behavior, though the underlying association remains poorly defined. We examine the association between nonmedical use of prescription opioids/opioid use disorder and suicidal ideation/attempts. We used longitudinal data from a national representative sample of the US adult population, the National Epidemiologic Survey on Alcohol and Related Conditions. Participants (n = 34 653) were interviewed in 2001-2002 (wave 1) and re-interviewed approximately 3 years later (wave 2). A propensity score analysis estimated the association between exposure to prescription opioids at wave 1 and prevalent/incident suicidal behavior at wave 2. Heavy/frequent (⩾2-3 times a month) prescription opioid use was associated with prevalent suicide attempts [adjusted risk ratio (ARR) = 2.75, 95% CI 1.35-5.60]. Prescription opioid use disorder was associated with prevalent (ARR = 1.98, 95% CI 1.20-3.28) and incident suicidal ideation (ARR = 2.59, 95% CI 1.25-5.37), and prevalent attempts (ARR = 4.19, 95% CI 1.71-10.27). None of the exposures was associated with incident suicide attempts. Heavy/frequent opioid use and related disorder were associated with prevalent suicide attempts; opioid use disorder was also associated with the incident and prevalent suicidal ideation. Given population increases in nonmedical use of prescription opioids and disorder, the opioid crisis may have contributed to population increases in suicidal ideation.
Sections du résumé
BACKGROUND
Since 1999, the rate of fatal prescription opioid overdoses and of suicides has dramatically increased in the USA. These increases, which have occurred among similar demographic groups, have led to the hypothesis that the opioid epidemic contributed to increases in suicidal behavior, though the underlying association remains poorly defined. We examine the association between nonmedical use of prescription opioids/opioid use disorder and suicidal ideation/attempts.
METHODS
We used longitudinal data from a national representative sample of the US adult population, the National Epidemiologic Survey on Alcohol and Related Conditions. Participants (n = 34 653) were interviewed in 2001-2002 (wave 1) and re-interviewed approximately 3 years later (wave 2). A propensity score analysis estimated the association between exposure to prescription opioids at wave 1 and prevalent/incident suicidal behavior at wave 2.
RESULTS
Heavy/frequent (⩾2-3 times a month) prescription opioid use was associated with prevalent suicide attempts [adjusted risk ratio (ARR) = 2.75, 95% CI 1.35-5.60]. Prescription opioid use disorder was associated with prevalent (ARR = 1.98, 95% CI 1.20-3.28) and incident suicidal ideation (ARR = 2.59, 95% CI 1.25-5.37), and prevalent attempts (ARR = 4.19, 95% CI 1.71-10.27). None of the exposures was associated with incident suicide attempts.
CONCLUSIONS
Heavy/frequent opioid use and related disorder were associated with prevalent suicide attempts; opioid use disorder was also associated with the incident and prevalent suicidal ideation. Given population increases in nonmedical use of prescription opioids and disorder, the opioid crisis may have contributed to population increases in suicidal ideation.
Identifiants
pubmed: 32635959
doi: 10.1017/S0033291720002160
pii: S0033291720002160
pmc: PMC7810360
mid: NIHMS1660604
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
372-378Subventions
Organisme : NIDA NIH HHS
ID : R01 DA037866
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA039962
Pays : United States
Références
Drug Alcohol Depend. 2015 Dec 1;157:192-6
pubmed: 26520564
Pain. 2016 May;157(5):1079-1084
pubmed: 26761386
Stat Methods Med Res. 2012 Jun;21(3):273-93
pubmed: 21262780
Adv Psychosom Med. 2011;30:22-60
pubmed: 21508625
Neuropsychopharmacology. 2001 Feb;24(2):97-129
pubmed: 11120394
Int J Psychiatry Med. 2014;47(2):169-74
pubmed: 25084802
Arch Gen Psychiatry. 2004 Apr;61(4):361-8
pubmed: 15066894
Soc Psychiatry Psychiatr Epidemiol. 2015 Nov;50(11):1609-40
pubmed: 26210739
MMWR Morb Mortal Wkly Rep. 2017 Mar 17;66(10):270-273
pubmed: 28301448
Subst Use Misuse. 2015;50(13):1678-89
pubmed: 26576505
Am J Epidemiol. 2019 Jul 1;188(7):1245-1253
pubmed: 30834448
NCHS Data Brief. 2016 Apr;(241):1-8
pubmed: 27111185
Drug Alcohol Depend. 2008 Jan 1;92(1-3):27-36
pubmed: 17706375
Arch Gen Psychiatry. 2004 Aug;61(8):807-16
pubmed: 15289279
Am J Psychiatry. 2016 May 1;173(5):491-8
pubmed: 26684923
Stat Med. 1998 Oct 15;17(19):2265-81
pubmed: 9802183
J Gen Intern Med. 2014 Mar;29(3):491-9
pubmed: 24165926
Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1166-75
pubmed: 19718704
Drug Alcohol Depend. 1995 Jul;39(1):37-44
pubmed: 7587973
Am J Epidemiol. 1989 Nov;130(5):1066
pubmed: 2816895
Drug Alcohol Depend. 2004 Dec 7;76 Suppl:S11-9
pubmed: 15555812
JAMA Psychiatry. 2017 Nov 1;74(11):1095-1103
pubmed: 28903161
Annu Rev Neurosci. 2006;29:565-98
pubmed: 16776597
Psychol Assess. 2016 Aug;28(8):1026-30
pubmed: 26502202
N Engl J Med. 2014 May 29;370(22):2063-6
pubmed: 24758595
N Engl J Med. 2019 Jan 3;380(1):71-79
pubmed: 30601750
NCHS Data Brief. 2017 Dec;(294):1-8
pubmed: 29319475
PLoS One. 2015 Oct 23;10(10):e0141606
pubmed: 26496707
Health Serv Res. 2014 Feb;49(1):284-303
pubmed: 23855598
J Stud Alcohol Drugs. 2012 Mar;73(2):178-84
pubmed: 22333325
Cochrane Database Syst Rev. 2014 Feb 06;(2):CD002207
pubmed: 24500948
JAMA Pediatr. 2016 Oct 1;170(10):971-978
pubmed: 27533915
Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2597-607
pubmed: 23988582
J Addict Med. 2015 Jan-Feb;9(1):61-7
pubmed: 25469652